Over 65abstracts were submitted a record-breaking number for ISCT showcasing the state of the art across the field of CGT translation. Thank you to all those who presented their work at ISCT 2023, and congratulations to the ISCT 2023 Abstract Award Winners.

Interested in another opportunity to showcase your research? You can also submit your ISCT 2023 Paris Abstracts to our upcoming North America Regional Meeting in September. Submit before June 19th and join us in Houston!

Submit now

Top Scoring Abstract Overall Sponsored by ISCT

Hannah Song, PhD
National Institutes of Health, USA

"CAR-T Cells Manufactured via Positive and Negative Immunomagnetic T Cell Selection Show Different Tumour Killing Rates, Cytokine Profiles, and γδ T Cell Output."

 Best Poster Award Sponsored by BioCanRx

Marco Alessandrini, PhD
Antion Biosciences, Switzerland

"Overcoming the Risk of Graft Versus Host Disease by Engineering Non-Alloreactive T-Cells Using a Tunable Expression Module (Tem) for High Efficiency Gene Silencing"

ISCT Technologist Awards - Sponsored by ISCT

Jiri Eitler, PhD
TU Dresden, Germany

"Dual Targeting of CAR-NK Cells to PDL1 and HER2 Facilities Specific Elimination of Cancer Cells of Solid Tumor Origin and Overcomes Immune Escape by Antigen Loss"

Nasser Masroori, PhD
Le Centre de Recherche de l'Hôpital Maisonneuve-Rosemont, University of Montreal, Canada


"Engineering T Cell Targeting Minor Histocompatibility Antigens"


Paramita Chatterjee, MSc, MBA
Georgia Institute of Technology, USA

"Single-Cell Transcriptomics Comparison Of Cell Therapeutics in Osteoarthritis"

ISCT Early Stage Professionals Awards - Sponsored by ISCT

Ashley Geiger, BSc, MSC
Children's National Medical Center, USA

"Multi-Tumor Associated Antigen-Specific T Cell (Taa-T) Therapy to Treat Pediatric Patients With High-Risk Cns Tumors: The Remind Trial"

Corby Fink, PhD

Western University; Robarts Research Institute, Canada

"In Vivo Tracking of Adenoviral-Transduced SPIO-labeled Bone Marrow-Derived Dendritic Cells Using MPI"


Laura Baque Vidal, MSc

Karolinska Institute, Sweden

"Manufacture And Release Testing Of Cellthrpe1 for Treatment Of Dry Age-Related Macular Degeneration"

ISCT Top Scoring Emerging Economies Abstract Award - Sponsored by Cytotherapy

Matheus Henrique dos Santos, MSc
University of São Paulo, Brazil

"Incorporation of 2b4 Signaling Domain in Anti-Cd19 Nk-Specific Cars Increases the Potency of Effector Functions Of Car-Nk Cells Against Malignant Cd19+ Cell Lines"

ISCT Top Scoring Stem Cell Engineering Abstract Award - Sponsored by ISCT Stem Cell Engineering Committee

Alice Bertaina, MD, PhD
Stanford University School of Medicine, USA

"T-allo10 Infusion after Aβdepleted-HSCT in Children and Young Adults with Hematologic Malignancies: Improved Immune Reconstitution in the Absence of Severe GvHD"

ISCT Top Scoring ANZ Region ESP Abstract Award in Memory of the late Geoffrey Symonds - Sponsored by ISCT Australia and New Zealand Regional Executive Committee

Katie Lineburg, BSc, PhD
QIMR Berghofer Medical Research Institute, Australia

"Harnessing Surface Expression to Define a Unique Memory T Cell Subset with Stem-Like Properties to Enhance Adoptive T Cell Therapies"

ISCT Best Elevator Pitch Abstract Award - Sponsored by Cytotherapy

Fabrizia Bonacina, PhD
Universita degli Studi di Milano, Italy

"Generation of Humanized Immunocompromised Dyslipidemic Rag2-KO/IL2rg-KO/CD47-KO/LDL-R KO Mice for the Study of Immunomodulatory Therapies for the Treatment of Atherosclerosis"

ESP Rookie of the Year Award

Tae-Yoon Park, PhD
McLean Hospital; Harvard Medical School Department of Psychiatry, USA

"Therapeutic Improvement of Parkinson’s Disease Transplantation Therapy Through Modulating the Immune System"

Top Scoring Orthopedic and Musculoskeletal Therapies Abstract Award sponsored by the ISCT Orthopedic and Musculoskeletal Therapies Committee

Kevin Robb, BSc, MESc
University of Toronto, Canada

"Patient Responses to Mesenchymal Stromal Cell (MSC) Therapy in Osteoarthritis are Associated with Differential Clinical Phenotypes, Molecular Endotypes, and MSC Critical Quality Attributes"

Top Scoring Canadian Abstract Award

Denis Claude Roy, MD
Hopital Maisonnneuve-Rosemont; CR-HMR; Universite de Montreal Faculte de Medecine, Canada

"Phase I clinical Trial of Anti-Minor Histocompatibility Antigen Expanded T-Cells to Target Leukemia Relapsing after Allogeneic HLA-Matched Transplantation"